Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04727658

Linac FRACtionated Radiosurgical THALamotomie in Tremors (FRACTHAL)

Linac FRACtionated Radiosurgical THALamotomy in Tremors : a Phase II Study

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Radiosurgical thalamotomy on GammaKnife has been shown to be effective in the management of tremors. However, several teams describe a significant risk of severe neurological complications. In addition, fitting the invasive frame and the need to travel to GammKnife centers often limit access to treatment in this population of elderly patients. Linear accelerators have greatly improved their precision, now reaching that of GammaKnife. A possible alternative is therefore to treat patients on linear accelerators, without an invasive frame. The objective of the FRACTHAL study is to assess the feasibility and safety of treatment of essential and / or parkinsonian tremor by fractional radiosurgical thalamotomy on a linear accelerator. The main hypothesis of the FRACTHAL study is based on the fact that dividing the dose into 3 sessions will both protect healthy tissue around the target while maintaining therapeutic efficacy on the treatment target.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiosurgical thalamotomy on GammaKnifefractional radiosurgical thalamotomy on an accelerator (3 sessions of 50 Gy at the isocenter )

Timeline

Start date
2021-07-01
Primary completion
2026-03-01
Completion
2027-03-01
First posted
2021-01-27
Last updated
2025-12-08

Locations

1 site across 1 country: Monaco

Source: ClinicalTrials.gov record NCT04727658. Inclusion in this directory is not an endorsement.